Pluto Bioinformatics

GSE144817: NIH-3T3 cell line response to proteasome inhibitor

Bulk RNA sequencing

In this study, we compared the transcriptional profile of NIH-3T3 cells that are either wild-type (WT) or Nrf1 knockout (Nrf1-KO). We treated these cells with carfilzomib for 6 hours or 24 hours and performed RNA-sequencing with these samples. SOURCE: Senthil Radhakrishnan (senthil.radhakrishnan@vcuhealth.org) - Virginia Commonwealth University